Conceptio › Archive › Europe PMC
Europe PMCopen access

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial

Hamonic G et al.
Europe PMC · Papers · License: Open Access
Open Source ↗Direct PDF ↓
Vaccine, Immunogenicity, Protein subunit, Clinical Trial, Phase 1, Booster
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 304184
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.